About this document "ctDNA MRD assay (Signatera™)": How much does ctDNA MRD assay (Signatera™) typically cost
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Based on the document content, the ctDNA MRD assay (Signatera™) costs $1000+. However, it's important to note two key points from the document:
-
Insurance Coverage: The test is currently listed as "No (investigational)" for insurance coverage
-
Clinical Context: According to the document, this test is currently for "Stage II-III post-op (clinical trial use)"
For context on testing costs and coverage, I should note that:
According to NCCN Guidelines for Colorectal Cancer (current version), while circulating tumor DNA (ctDNA) testing is an emerging technology for monitoring disease, it is still considered investigational in many contexts.
The American Society of Clinical Oncology (ASCO) guidelines also indicate that while ctDNA testing shows promise for monitoring colorectal cancer, more evidence is needed before it becomes standard of care, which affects both insurance coverage and out-of-pocket costs for patients.
I would recommend:
- Discussing with your healthcare provider about the necessity and timing of this test
- Checking with your specific insurance provider about any potential coverage
- Asking about any available financial assistance programs or clinical trial opportunities that might cover testing costs
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with financial for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ